GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,650,000 | +1.8% | 83,866 | +1.9% | 0.29% | -9.3% |
Q1 2022 | $3,586,000 | -1.2% | 82,318 | 0.0% | 0.32% | +4.5% |
Q4 2021 | $3,630,000 | +14.6% | 82,318 | -0.7% | 0.31% | +4.1% |
Q3 2021 | $3,168,000 | -4.1% | 82,918 | 0.0% | 0.30% | -3.6% |
Q2 2021 | $3,302,000 | +11.4% | 82,918 | -0.2% | 0.31% | +6.6% |
Q1 2021 | $2,965,000 | -3.5% | 83,068 | -0.5% | 0.29% | -6.5% |
Q4 2020 | $3,073,000 | -3.3% | 83,518 | -1.0% | 0.31% | -12.3% |
Q3 2020 | $3,177,000 | -7.7% | 84,402 | 0.0% | 0.35% | -11.8% |
Q2 2020 | $3,443,000 | +7.7% | 84,402 | 0.0% | 0.40% | -7.7% |
Q1 2020 | $3,198,000 | -19.8% | 84,402 | -0.5% | 0.43% | -1.1% |
Q4 2019 | $3,986,000 | +10.1% | 84,818 | 0.0% | 0.44% | +3.8% |
Q3 2019 | $3,620,000 | +5.8% | 84,818 | -0.8% | 0.42% | +5.5% |
Q2 2019 | $3,420,000 | -4.5% | 85,464 | -0.3% | 0.40% | -7.2% |
Q1 2019 | $3,581,000 | +9.2% | 85,691 | -0.1% | 0.43% | -1.6% |
Q4 2018 | $3,278,000 | -4.9% | 85,785 | 0.0% | 0.44% | +11.5% |
Q3 2018 | $3,446,000 | -0.3% | 85,785 | 0.0% | 0.39% | -6.2% |
Q2 2018 | $3,458,000 | +3.3% | 85,785 | +0.2% | 0.42% | +1.7% |
Q1 2018 | $3,346,000 | +8.3% | 85,636 | -1.7% | 0.41% | +13.9% |
Q4 2017 | $3,090,000 | -13.1% | 87,110 | -0.6% | 0.36% | -16.3% |
Q3 2017 | $3,557,000 | -5.8% | 87,619 | 0.0% | 0.43% | -5.1% |
Q2 2017 | $3,778,000 | -1.5% | 87,619 | -3.7% | 0.45% | +1.1% |
Q1 2017 | $3,835,000 | 0.0% | 90,978 | -8.6% | 0.45% | +5.9% |
Q4 2016 | $3,835,000 | -10.7% | 99,585 | 0.0% | 0.42% | -13.0% |
Q3 2016 | $4,295,000 | -1.3% | 99,585 | -0.8% | 0.49% | -4.0% |
Q2 2016 | $4,350,000 | +6.8% | 100,373 | -0.1% | 0.51% | +1.8% |
Q1 2016 | $4,073,000 | +0.5% | 100,461 | 0.0% | 0.50% | -2.4% |
Q4 2015 | $4,053,000 | +4.9% | 100,461 | 0.0% | 0.51% | -0.6% |
Q3 2015 | $3,863,000 | -8.2% | 100,461 | -0.5% | 0.51% | +0.2% |
Q2 2015 | $4,207,000 | -9.8% | 101,010 | -0.1% | 0.51% | -9.7% |
Q1 2015 | $4,665,000 | +7.4% | 101,089 | -0.6% | 0.57% | +4.2% |
Q4 2014 | $4,345,000 | -7.1% | 101,658 | -0.1% | 0.54% | -9.5% |
Q3 2014 | $4,677,000 | -14.1% | 101,747 | 0.0% | 0.60% | -12.0% |
Q2 2014 | $5,442,000 | +0.7% | 101,747 | +0.6% | 0.68% | -1.7% |
Q1 2014 | $5,403,000 | +0.1% | 101,127 | 0.0% | 0.69% | -1.0% |
Q4 2013 | $5,399,000 | +5.1% | 101,127 | -1.2% | 0.70% | -2.6% |
Q3 2013 | $5,135,000 | +0.5% | 102,356 | +0.1% | 0.72% | -2.6% |
Q2 2013 | $5,107,000 | +3.4% | 102,204 | -3.0% | 0.74% | -2.0% |
Q1 2013 | $4,941,000 | – | 105,329 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |